Journal profile
Novelty in Clinical Medicine
ISSN 2783-4492 · eISSN 3041-9921 · Sadra Danesh Negar · Kazakhstan
Novelty in Clinical Medicine: diamond open access (no APC); no APC; review about 25 days (submission to acceptance, publisher); acceptance rate 30% (journal website).
Scope
Aims, scope and focus
Journal of Preventive and Complementary Medicine (eISSN: 3041-9921, pISSN: 3041-9700) aims to provide a platform for researchers, academicians, healthcare professionals, and policymakers to publish high-quality research articles, reviews, and original papers in the field of preventive medicine, complementary and alternative medicine, integrative medicine, public health, and related disciplines. The journal focuses on promoting preventive strategies, lifestyle interventions, complementary and alternative therapies, and holistic approaches to health and wellness.
From the journal's Aims & Scope
Editor-in-chief Michael NordvallPublisher website
Editorial board by country: none in mainland China; most named Iran 8, United States 5, Germany 1, Brazil 1, Türkiye 1 (19 members with a country) Editorial board ↗Publisher website ·
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
DOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EBSCOPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- h-index
- 0OpenAlex ·
- i10-index
- 0OpenAlex ·
- 2-year mean citedness
- 0OpenAlex ·
- Share of gold OA articles
- 0%LetPub ·
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
Too few articlesOnly 1 articles from the last 24 months carry both submission and acceptance dates, too few for a median
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Figures by source
- Average review time (community reports)
- about 4 weeksLetPub ·
- Acceptance rate (publisher)
- 30%Publisher website ·
- Submission to first decision
- 14 daysPublisher website ·
- First decision after review
- 50 daysPublisher website ·
- Submission to acceptance
- 25 daysPublisher website ·
- Acceptance to publication
- 25 daysPublisher website ·
- Submission to publication (journal-reported)
- about 4 weeksDOAJ ·
- Peer review
- Double anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Diamond open access (no APC)DOAJ
Every article is open access and authors pay no article processing charge.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | No APC | No | CC BY-NC | |
| LetPub | No APC | No | — | |
| Publisher website | No APC | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Keywords
- ≥ 3
- Manuscript length
- ≤ 4,000 words
- Reference style
- Vancouver
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Trial registration / reporting guidelines
- Authorship Authorship
Based on the ICJME recommendations "all those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Those who do not meet all four criteria should be acknowledged". Author's contribution should be stated in the declaration section. All authors should be accountable for all sections of the manuscript and declare that …
Source ↗Publisher website ·- Conflicts of interest Conflict of Interest
Authors are expected to disclose any commercial associations or sources of support that might pose a conflict of interest regarding the submitted article.
Source ↗Publisher website ·- Data availability Data Availability
Author(s) should guarantee that data of the study are available and will be provided if anyone needs them.
Source ↗Publisher website ·- Publication ethics
Conforms to international regulations against scientific misconduct (fabrication, falsification, plagiarism); suspected misconduct assessed during peer-review and publication based on COPE guidelines. Model summary
Journal of Preventive and Complementary Medicine conforms to the international regulations against scientific misconduct including fabrication, falsification, plagiarism, and etc.
Source ↗Publisher website ·- License & copyright
Published under a Creative Commons Attribution-NonCommercial 4.0 International License. Model summary
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Source ↗Publisher website ·- Trial registration / reporting guidelines Reporting Guidelines for Specific Study Designs
The reporting guidelines for other type of studies can be found at https://www.equator-network.org/reporting-guidelines/.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Sadra Danesh Negar
- Country or region
- Kazakhstan
- Language
- English
- ISSN
- 2783-4492
- Print ISSN
- 3041-9700
- Electronic ISSN
- 3041-9921
- Latest issue on the website
- Volume 5, Issue 2 (2026)
- Official links
FAQ
Frequently asked questions about Novelty in Clinical Medicine
How long does peer review take at Novelty in Clinical Medicine?
The publisher reports about 25 days (submission to acceptance); authors report an average review time of about 4 weeks; the journal's website gives an acceptance rate of 30%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Novelty in Clinical Medicine?
According to the journal's author guidelines: Keywords: ≥ 3; Manuscript length: ≤ 4,000 words; Reference style: Vancouver. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Novelty in Clinical Medicine based?
Of the 19 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Iran (8), United States (5) and Germany (1). Counted from the institutions listed on the board page; for reference only.
Which databases index Novelty in Clinical Medicine?
According to LetPub and DOAJ records, Novelty in Clinical Medicine is indexed in DOAJ.
Is Novelty in Clinical Medicine open access, and what is the APC?
Novelty in Clinical Medicine is a diamond open-access journal (no APC). It charges no article processing charge.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .